2011
DOI: 10.1017/s0029665111004265
|View full text |Cite
|
Sign up to set email alerts
|

Home Parenteral Nutrition (HPN): An international benchmarking exercise

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…In 2012, the period prevalence of HPN in 16 European countries was estimated to range from 3.25 to 66 patients per million of the population (9). The most common indication for HPN in adults is short bowel arising from underlying diseases such as mesenteric ischemia and Crohn's disease; motility disorders and bowel obstruction due to cancer (7).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In 2012, the period prevalence of HPN in 16 European countries was estimated to range from 3.25 to 66 patients per million of the population (9). The most common indication for HPN in adults is short bowel arising from underlying diseases such as mesenteric ischemia and Crohn's disease; motility disorders and bowel obstruction due to cancer (7).…”
Section: Introductionmentioning
confidence: 99%
“…At 10 years 84% are still dependent on HPN and a significant number live 20 years or longer (8)(9)(10)(11)(12)(13)(14). In 2009 ESPEN published guidelines for the use of HPN in adults (15) and recognised the lack of studies describing QOL in HPN patients using disease-specific tools; it was noted that measurement of QOL should be patient-based rather than the clinician's perspective.…”
Section: Introductionmentioning
confidence: 99%